Chemoinformaics analysis of indole-3-alkylmamines – hypaphorine
Molecular Weight | 246.31 | nRot | 4 |
Heavy Atom Molecular Weight | 228.166 | nRig | 11 |
Exact Molecular Weight | 246.137 | nRing | 2 |
Solubility: LogS | 0.322 | nHRing | 1 |
Solubility: LogP | -2.079 | No. of Aliphatic Rings | 0 |
Acid Count | 1 | No. of Aromatic Rings | 2 |
Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 36 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 1 |
nHetero | 4 | No. of Aromatic Hetero Cycles | 1 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 2 | No. of Arom Atom | 9 |
No. of Oxygen atom | 2 | No. of Arom Bond | 10 |
nHA | 2 | APOL | 39.1863 |
nHD | 1 | BPOL | 22.6437 |
QED | 0.8 |
Synth | 3.382 |
Natural Product Likeliness | 0.31 |
NR-PPAR-gamma | 0.005 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.001 |
Pgp-sub | 0.113 |
HIA | 0.739 |
CACO-2 | -5.505 |
MDCK | 0.0000138 |
BBB | 0.317 |
PPB | 0.119969 |
VDSS | 0.817 |
FU | 0.847367 |
CYP1A2-inh | 0.037 |
CYP1A2-sub | 0.879 |
CYP2c19-inh | 0.035 |
CYP2c19-sub | 0.054 |
CYP2c9-inh | 0.007 |
CYP2c9-sub | 0.815 |
CYP2d6-inh | 0.008 |
CYP2d6-sub | 0.794 |
CYP3a4-inh | 0.008 |
CYP3a4-sub | 0.057 |
CL | 3.09 |
T12 | 0.943 |
hERG | 0.004 |
Ames | 0.003 |
ROA | 0.444 |
SkinSen | 0.028 |
Carcinogencity | 0.066 |
EI | 0.141 |
Respiratory | 0.03 |
NR-Aromatase | 0.004 |
Antiviral | No |
Prediction | 0.621798 |